Sugi Predict

Sugi Predict / Compounds / SCHEMBL18565477

SCHEMBL18565477

SCHEMBL18565477

Cn1c2ccc(-c3ccc4c(c3)C3(c5ccccc5-c5ccccc53)c3ccccc3-4)cc2c2c3ccccc3c3ccccc3c21

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 12/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ ALKBH5 Q6P6C2 1/20 0.33
▸ FTO Q9C0B1 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RET P07949 1/20 0.32
▸ HSD17B10 Q99714 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ GLA P06280 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ GPR3 P46089 1/20 0.30
▸ CHEK1 O14757 1/20 0.30
▸ WEE1 P30291 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18565476 0.93 MAOB (0.32) PDK2HSP90AA1IDO1ALKBH5FTO
SCHEMBL18565465 0.90 MAOB (0.37) PDK2HSP90AA1IDO1ALKBH5FTO
SCHEMBL18565473 0.89 PDK2 (0.33) PDK2HSP90AA1IDO1ALKBH5FTO
SCHEMBL18565481 0.84 ALKBH5 (0.35) PDK2HSP90AA1IDO1ALKBH5FTO
SCHEMBL18565469 0.84 PDK2 (0.33) PDK2
SCHEMBL18565478 0.83 MAOB (0.39) PDK2HSP90AA1IDO1KDM4EMAPT
SCHEMBL17125533 0.83 GPR3 (0.46) PDK2KDM4EMAPTHSD17B10ALDH1A1
SCHEMBL13433119 0.83 GPR3 (0.46) PDK2KDM4EMAPTHSD17B10ALDH1A1
SCHEMBL18565444 0.81 NQO2 (0.33) PDK2KDM4EMAPTHSD17B10ALDH1A1
SCHEMBL18565370 0.81 ALKBH5 (0.45) PDK2HSP90AA1IDO1ALKBH5FTO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 — — US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 PDK2 4209/4885HSP90AA1 4595/4885IDO1 1153/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 PDK2 4209/4885HSP90AA1 4595/4885IDO1 1153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.